Transcription of Thames Valley SACT Regimens
{{id}} {{{paragraph}}}
Thames Valley Gynae SACT Regimens 1 Thames Valley SACT Regimens Gynaecological Cancer Thames Valley Gynae SACT Regimens Page 2 of 86 Notes from the editor Theseregimens are available on the Network website Any correspondence about the Regimens should be addressed to: Sally Coutts, Cancer Pharmacist, Thames Valley email: Tel: 01865 857166 Acknowledgements These Regimens have been compiled by the Network Pharmacy Group in collaboration with the Gynae CAG with key contribution from Dr Bernadette Lavery, Consultant Oncologist, OUH Dr Clive Charlton, Consultant Oncologist, RBFT Dr Marcia Hall, Consultant Oncologist, HWP Prof Sean Kehoe, Consultant Gynaecologist, OUH Karen Carter, Oncology Pharmacist, RBFT Thames Valley Cancer Network.
Carboplatin AUC7 Dysgerminoma and seminoma 29 Methotrexate 50 Germ cell 30 Methotrexate weekly Germ cell 31 Bevacizumab 7.5mg/kg Ovarian, fallopian, peritoneal 32 Carboplatin desensitisation 34 Niraparib Ovarian, fallopian tube, peritoneal 36 Paclitaxel carboplatin 21 day Ovarian + endometrial + cervical 39
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}